Market Monitor chemicals United Kingdom 2018

マーケットモニター

  • イギリス
  • 化学・薬品

19 7 2018

Good short-term outlook for the chemicals sector, but Brexit poses a downside risk for businesses profitability and payment behaviour in the mid-term.

 

 

UK chemicals 2018 pic1

  • The British chemicals and pharmaceuticals industries add about GBP 18 billion of value to the UK economy every year, and combined they are the largest exporter of manufactured goods. The chemicals segment accounts for 6.8% of UK gross value added manufacturing, whilst pharmaceuticals contributes 7.7%. Chemicals and chemical products account for about 4.5% of exported goods, while pharmaceutical products represent 8.2% of goods exported. Compared to other sectors business investment is high, at about GBP 4.3 billion in 2017.
  • The chemicals and pharmaceuticals industries mainly comprise small to medium Enterprises (SMEs) and microbusinesses, while a number of major firms are headquartered in the UK. The majority of businesses are mature with a stable customer base, as high entry barriers protect the industries (regulatory requirements and required high capital expenditure).
  • Chemicals contribute to a range of sectors such as aerospace and automotive through the provision of coatings, adhesives, rubbers and plastics. It also provides intermediary ingredients to pharmaceuticals, cosmetics, agrochemical, personal care, paint and home care sectors. The pharmaceutical sector is part of a global industry in which the UK is a leading European market and producer.   
  • A large number of chemicals businesses rely on asset-based finance for financing. In most cases profit levels are sufficient to cover the interest. Bank financing facilities are adequate, and business refinancing does not appear to be a problem.   

  • On average, payments in the British chemicals sector take between 60 days and 90 days. Payment experience has been very good over the past couple of years, and the level of protracted payments is low. The number of non-payment and insolvency cases was low in 2017 and 2016, and this trend should largely remain unchanged in 2018.

  • For the time being our underwriting approach to the chemicals sector remains generally positive for all major subsectors (basic chemicals, petrochemicals, fine and specialty chemicals). The same accounts for the pharmaceuticals industry.

  • However, the potential repercussions of Brexit on the domestic economy pose a downside risk for businesses profitability and payment behaviour in the mid-term. Both chemicals and pharmaceuticals are part of a tightly integrated EU supply chain that relies on friction-free transfer of ingredients and finished products. At the same time, the EU accounts for 60% of British chemicals and pharmaceuticals exports.

     

     

     

     

     

     

関連ドキュメント

免責条項

本ウェブサイトの記載事項は、一般的な情報提供のみを目的とし、何らの目的においてもこれに依拠すべきではありません。規定条件については、実際の保険契約または該当の製品・サービス契約をご覧ください。本ウェブサイトの記載事項は、買主についてのまたは利用者の代理人としてのデューデリジェンスの実施義務を含め、アトラディウス側に何らの権利、義務または責任を生じさせるものではありません。アトラディウスが買主についてデューデリジェンスを実施する場合は、当社の保険引受をその目的とし、被保険者その他の利益を目的とするものではありません。さらに、アトラディウスおよびその関連会社、系列会社、子会社は、本ウェブサイトの掲載情報の利用によって生じた直接的、間接的、特異的、付随的、結果的損害について一切の責任を負いません。